Ira D Glick

Clinical Focus

• Psychiatry

Administrative Appointments

• Acting Deputy Chief of Staff and Chief of Psychiatry, Palo Alto Veterans, Stanford University School of Medicine & Stanford University Hospital (1995 - 1996)
• Director of Inpatient & Partial Hospitalization Services, Stanford University School of Medicine & Stanford University Hospital (1993 - 2000)
• Director, Schizophrenia Research Clinic, Stanford University School of Medicine & Stanford University Hospital (1993 - present)
• Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine (1993 - present)
• Senior Science Advisor to the Director, National Institute of Mental Health, Rockville, MD, 80% (1988 - 1990)
View All 18administrative appointments of Ira Glick

Honors and Awards

• Skull & Key Award, Dickinson College (1953-1954)
• National Foundation Medical Student Fellowship, Dept. of Physical Medicine & Rehabilitation, New York Medical College (Summer) (1959)
• Dept. of Psychiatry, New York Medical College (Summer), National Institute of Mental Health Research Training Grant (1960)
• Stephen P. Jewett Award ., Dept. of Psychiatry, New York Medical College (1961)
• Army Commendation Medal, U.S. Army Hospital, Ft. Gordon, Georgia (1968)

Professional Education

Graduate & Fellowship Program Affiliations

• Psychiatry and Behavioral Science

Industry Relationships

Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information

Current Research Interests

Schizophrenia is one of the major public health problems in American medicine. Treatment is partially efficacious but unsatisfactory. Accordingly, our research focuses on treatment outcome in two areas; finding more effective medications which have less side effects than current medications, and in the effects of combining medication with psychosocial interventions.

Clinical Trials

• Comparison of Antipsychotics for Metabolic Problems (CAMP) in the Treatment of People With Schizophrenia or Schizoaffective Disorder Recruiting

Publications

• Psychiatric conditions in sports: diagnosis, treatment, and quality of life. Glick ID, Horsfall JL. Phys Sportsmed. 2009; 37 (3): 29-34
• Onset and persistence of antipsychotic response in patients with schizophrenia. Glick ID, Bossie CA, Alphs L, Canuso CM. J Clin Psychopharmacol. 2009; 29 (6): 542-7
• The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials. Glick ID, Mankoski R, Eudicone JM, Marcus RN, Tran QV, Assunção-Talbott S. J Affect Disord. 2009; 115 (1-2): 18-26
• A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. Glick ID, Bosch J, Casey DE. J Clin Psychopharmacol. 2009; 29 (3): 267-71
• The evolution of sport psychiatry, circa 2009. Glick ID, Kamm R, Morse E. Sports Med. 2009; 39 (8): 607-13